Page 117 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
• The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-
Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023. San Diego,
CA, USA. Blood. 2023;142(Supplement 1):974. https://doi.org/10.1182/blood-2023-180482.
Mosquera Orgueira A, Pérez Encinas M, Díaz Arias JA, Rodríguez Veiga R, Bergua Bur-
gués JM, Lorenzo Algarra J, Botella C, Pérez Simón JA, Bernal T, Tormo M, Calbacho M,
Salamero O, Serrano J, Noriega V, López López JA, Vives S, Colorado M, López Lorenzo
JL, Vidriales Vicente M, García Boyero R, Olave Rubio MT, Herrera Puente P, Arce O, Ba-
rrios García M, Sayas Lloris MJ, Polo M, Gómez Roncero MI, Barragán E, Ayala R, Chillón
C, Calasanz MJ, Boluda B, Peleteiro Raindo A, Amigo R, Martínez Cuadrón D, Labrador J,
Montesinos P.
• Minimal Residual Disease Detection By Single Cell DNA Sequencing Technology:
A Feasible Approach for Clinical Application and Identification of the Landscape of
MRD Clones.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023. San Diego,
CA, USA. Blood. 2023;142(Supplement 1):2958. https://doi.org/10.1182/blood-2023-188865.
Alfonso Piérola A, Ariceta B, Vilas-Zornoza A, Aguirre-Ruiz P, Sarvide S, San-Martín P,
Fortuño MA, Simoes C, Burgos L, Larrayoz MJ, Chillón C, Arce O, Bernal Del Castillo T,
Colorado M, Cuevas Palomares L, Marchante I, Mateos MC, Olave M, Pérez-Simón JA,
Calasanz MJ, García-Sanz R, Paiva B, Montesinos P, Prósper F.
• Treatment Outcomes in Unfit Patients with Newly Acute Myeloid Leukemia Accord-
ing to IDH1 Mutational Status: Real World Evidence from the Pethema Epidemiologic
Registry.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023. San Diego,
CA, USA. Blood. 2023;142(Supplement 1):4223. https://doi.org/10.1182/blood-2023-189800.
Martínez-Cuadrón D, Boluda B, Lorenzo Algarra J, Bergua Burgués JM, Rodríguez Veiga
R, Martínez Sánchez P, Serrano J, Ramos-Ortega FJ, Pérez-Simón JA, Tormo M, López
Lorenzo JL, Lavilla E, Bernal Del Castillo T, Rodríguez-Medina C, García Garay MC, Sayas
Lloris MJ, Gil C, Olave Rubio MT, García Boyero R, Vives S, Foncillas MA, Labrador J, Ibá-
ñez F, Cabello A, Herrera Puente P, González González BJ, Barragán E, Sargas C, Ayala
R, Chillón C, Montesinos P.
• A High Percentage of DNAM-1+ and Low Percentage of Tactile+ NK Cells at Diag-
nosis Correlate with Complete Response and Survival in AML: A Sub-Analysis of the
Ven-a-Qui Pethema Trial.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023. San Diego,
CA, USA. Blood. 2023;142(Supplement 1):2960. https://doi.org/10.1182/blood-2023-189676.
117